Does it eliminate side effects?

No. Urinary, sexual, and infectious risks remain, and additional treatment may be needed.

Do I need follow-up afterward?

Yes. PSA, MRI, and often follow-up biopsy are central to the strategy.

How is reliable lesion localization confirmed?

The team looks for agreement between multiparametric MRI, targeted and systematic biopsy, grade, volume, and tumor distribution before considering focal treatment.

What if cancer appears outside the treated area?

Follow-up may identify persistent, recurrent, or new disease. Surveillance, repeat focal treatment, or whole-gland treatment may then be discussed according to findings.

Illustrative image

Focal therapy

Focal therapy with rigorous selection.

Guidance on focal therapy for localized prostate cancer in carefully selected patients.

Focal therapy aims to treat a defined area of the prostate rather than the whole gland. It is not suitable for every tumor and requires correlation between MRI, targeted and systematic biopsy, cancer characteristics, and the ability to maintain follow-up.

Request an evaluation

10+ years

of clinical and surgical experience

7,000+

cases treated

International training

Argentina, Spain, and the United Kingdom

Advanced specialist care

What must be clear first

Reliable localization

The clinically relevant lesion should correlate across imaging and biopsy.

Appropriate risk

Grade, volume, distribution, and stage must be reviewed individually.

Commitment to follow-up

PSA, MRI, and repeat biopsy may be needed after treatment.

Structured evaluation

Responsible selection

The question is not only whether a lesion can be treated, but whether doing so offers a reasonable balance.

Review diagnosis

Pathology, MRI quality, and agreement between samples are confirmed.

Map disease

The evaluation considers clinically relevant cancer outside the proposed target.

Compare alternatives

Surveillance, focal therapy, and whole-gland treatments are compared.

Agree on monitoring

Close follow-up is explained as an essential part of the strategy.

Informed decisions

A balanced conversation

Potential functional benefits must be weighed against cancer uncertainty, retreatment, and monitoring.

Localized objective

Treat the identified tumor area while preserving non-target tissue when reasonable.

Technology by case

Modality depends on anatomy, location, expertise, and availability.

Persistence or recurrence risk

Residual cancer, a new focus, or additional treatment may occur.

Ongoing surveillance

Follow-up continues after the procedure and may include confirmatory biopsies.

Prepare for your visit

What to bring for eligibility review

Multiparametric MRI and DICOM files
Complete biopsy report and core details
PSA history
Prior treatment opinions or plans

Explore related pathways

Cáncer de próstata Biopsia de próstata Solicitar segunda opinión

Safety notice

Focal therapy should not be presented as universally equivalent to surgery or radiation. Selection, limitations, follow-up, and alternatives need complete discussion.

Frequently asked questions

Answers to prepare your next step.

No. It is an option for selected patients and should be compared with active surveillance and whole-gland treatments.

Medical reference sources

Educational content remains reviewable. Guidelines support the conversation but do not replace individual clinical judgment.

National Cancer Institute · Prostate cancer National Cancer Institute · Prostate cancer treatment

The information on this page does not replace a medical consultation. If you have blood in your urine, urinary retention, fever, severe pain, or an elevated PSA, request an evaluation with a urologist.